FI915832A0 - Foerfarande foer maerkning av proteiner med teknetium eller rhenium. - Google Patents

Foerfarande foer maerkning av proteiner med teknetium eller rhenium.

Info

Publication number
FI915832A0
FI915832A0 FI915832A FI915832A FI915832A0 FI 915832 A0 FI915832 A0 FI 915832A0 FI 915832 A FI915832 A FI 915832A FI 915832 A FI915832 A FI 915832A FI 915832 A0 FI915832 A0 FI 915832A0
Authority
FI
Finland
Prior art keywords
rhenium
teknetium
proteiner
eller
med
Prior art date
Application number
FI915832A
Other languages
English (en)
Finnish (fi)
Inventor
Gary L Griffiths
Original Assignee
Immunomedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunomedics Inc filed Critical Immunomedics Inc
Publication of FI915832A0 publication Critical patent/FI915832A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI915832A 1989-06-12 1991-12-11 Foerfarande foer maerkning av proteiner med teknetium eller rhenium. FI915832A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36437389A 1989-06-12 1989-06-12
US07/392,280 US5128119A (en) 1989-06-12 1989-08-10 Methods for technetium/rhenium labeling of f(ab1)2 fragments
PCT/US1990/003142 WO1990015626A1 (en) 1989-06-12 1990-06-11 Methods for technetium/rhenium labelling of proteins

Publications (1)

Publication Number Publication Date
FI915832A0 true FI915832A0 (fi) 1991-12-11

Family

ID=27002452

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915832A FI915832A0 (fi) 1989-06-12 1991-12-11 Foerfarande foer maerkning av proteiner med teknetium eller rhenium.

Country Status (12)

Country Link
US (1) US5128119A (de)
EP (1) EP0403225B1 (de)
JP (1) JP2769244B2 (de)
KR (1) KR0178961B1 (de)
AT (1) ATE149515T1 (de)
AU (1) AU647028B2 (de)
CA (1) CA1335268C (de)
DE (1) DE69030025T2 (de)
ES (1) ES2098250T3 (de)
FI (1) FI915832A0 (de)
IL (1) IL94690A (de)
WO (1) WO1990015626A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897255A (en) * 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5393512A (en) * 1985-01-14 1995-02-28 Vanderheyden; Jean-Luc Stable therapeutic radionuclide compositions and methods for preparation thereof
CA1329119C (en) * 1988-03-29 1994-05-03 Milton David Goldenberg Cytotoxic therapy
US5612016A (en) * 1988-04-01 1997-03-18 Immunomedics, Inc. Conjugates of antibodies and bifunctional ligands
US5061641A (en) * 1988-04-01 1991-10-29 Immunomedics, Inc. Method for radiolabeling proteins
US5078985A (en) * 1989-08-09 1992-01-07 Rhomed, Incorporated Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction
US5346687A (en) * 1989-08-09 1994-09-13 Rhomed Incorporated Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging
US5460785A (en) * 1989-08-09 1995-10-24 Rhomed Incorporated Direct labeling of antibodies and other protein with metal ions
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
EP0486622B1 (de) * 1989-08-09 1998-11-04 Rhomed, Incorporated Direkte radioetikettierung von antikörpern und sonstigen proteinen mittels technetium oder rhenium
US5985240A (en) * 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
US5700444A (en) * 1992-02-20 1997-12-23 Rhomed Incorporated Chemotactic peptide pharmaceutical applications
US5759515A (en) * 1989-08-09 1998-06-02 Rhomed Incorporated Polyvalent peptide pharmaceutical applications
US5011676A (en) * 1990-03-27 1991-04-30 Thomas Jefferson University Method to directly radiolabel antibodies for diagnostic imaging and therapy
US5277892A (en) * 1990-08-08 1994-01-11 Rhomed Incorporated In vivo lymphocyte tagging
EP0498333B1 (de) * 1991-02-05 1997-01-15 Cis Bio International Verfahren zur Herstellung einer mit Technetium-99m markierten organspezifischen Substanz
AU658403B2 (en) * 1991-02-27 1995-04-13 Akzo N.V. Technetium-99m labeling of proteins
US5317091A (en) * 1991-02-27 1994-05-31 Akzo N.V. Technetium-99m labeling of proteins
EP0516873A1 (de) * 1991-06-06 1992-12-09 THE STATE of ISRAEL Atomic Energy Commission Soreq Nuclear Research Center Verfahren und Ausrüstung zur Markierung von Proteinen mit 99 mTC
US5225180A (en) * 1991-09-10 1993-07-06 Diatech, Inc. Technetium-99m labeled somatostatin-derived peptides for imaging
DE69231586T2 (de) * 1992-01-03 2001-07-19 Rhomed Inc Pharmazeutische anwendungen auf der basis von peptid-metall-ionen
US5643549A (en) * 1992-02-20 1997-07-01 Rhomed Incorporated Leukostimulatory agent for in vivo leukocyte tagging
US5403573A (en) * 1992-04-23 1995-04-04 The Curators Of The University Of Missouri Radiolabeled protein composition and method for radiation synovectomy
US5744119A (en) * 1993-05-11 1998-04-28 Sterling Winthrop Preparation of a radioconjugate formulation
US5746996A (en) * 1994-06-03 1998-05-05 Immunomedics, Inc. Thiolation of peptides for radionuclide-based radiodetection and radiotherapy
IL113610A0 (en) * 1994-06-03 1995-08-31 Immunomedics Inc A method of radiolabeling a protein, radiolabeled proteins prepared thereby and diagnostic kits containing the same
US5670132A (en) * 1994-09-20 1997-09-23 Immunomedics, Inc. Modified radioantibody fragments for reduced renal uptake
EP0910407B1 (de) 1996-05-15 2003-02-26 Altarex Corp. Verfahren und zusammensetzung zur umgestaltung multi-epitopischer antigene um die immunantwort einzuleiten
US8038994B2 (en) 1996-05-15 2011-10-18 Quest Pharmatech Inc. Combination therapy for treating disease
US6080384A (en) * 1997-03-25 2000-06-27 American Biogenetic Sciences, Inc. Methods for radionuclide-labeling of biomolecules and kits utilizing the same
KR100501534B1 (ko) * 1997-12-23 2005-10-26 정재민 방사성 동위원소 치료를 위한 방사성 레늄주석콜로이드 및 그 제법
DE19911329A1 (de) * 1998-03-27 2000-09-21 Benes Ivan Friedrich Humantherapeutisch anwendbares Radioimmunkonjugat und Verfahren zu seiner Herstellung
US7405320B2 (en) 1998-06-22 2008-07-29 Immunomedics, Inc. Therapeutic and diagnostic conjugates for use with multispecific antibodies
US7387772B1 (en) * 1999-06-22 2008-06-17 Immunimedics, Inc. Chimeric, human and humanized anti-CSAP monoclonal antibodies
US7833528B2 (en) * 1998-06-22 2010-11-16 Immunomedics, Inc. Use of multispecific, non-covalent complexes for targeted delivery of therapeutics
US6962702B2 (en) * 1998-06-22 2005-11-08 Immunomedics Inc. Production and use of novel peptide-based agents for use with bi-specific antibodies
US7138103B2 (en) * 1998-06-22 2006-11-21 Immunomedics, Inc. Use of bi-specific antibodies for pre-targeting diagnosis and therapy
KR100445971B1 (ko) * 2002-04-15 2004-08-25 한국원자력연구소 수소화붕소 교환수지를 이용한 테크네튬 또는 레늄의표지방법
US7651689B2 (en) * 2002-11-15 2010-01-26 Albert Einstein College Of Medicine Of Yeshiva University Methods of applying ionization radiation for therapy of infections
US7172751B2 (en) * 2003-06-13 2007-02-06 Immunomedics, Inc. D-amino acid peptides
AU2004259028C1 (en) * 2003-07-24 2009-12-24 Bracco Imaging S.P.A. Stable radiopharmaceutical compositions and methods for preparation
WO2005086612A2 (en) * 2003-07-29 2005-09-22 Immunomedics, Inc. Fluorinated carbohydrate conjugates
US7837980B2 (en) * 2004-03-02 2010-11-23 Seattle Genetics, Inc. Partially loaded antibodies and methods of their conjugation
DK3332808T3 (da) 2005-03-03 2020-12-14 Immunomedics Inc Humaniserede L243-antistoffer
EP2674440B1 (de) 2005-12-16 2019-07-03 IBC Pharmaceuticals, Inc. Polyvalente bioaktive anordnungen auf immunglobulinbasis
US20090163698A1 (en) * 2007-05-11 2009-06-25 John Joseph Grigsby Method for Preparing Antibody Conjugates
EP2204377A1 (de) * 2008-12-30 2010-07-07 Commissariat à l'énergie atomique et aux énergies alternatives Cysteinfreie, Technetium- oder Rhenium-chelatisierende Peptidsequenzen und deren Verwendung
CN107207379B (zh) 2014-11-25 2021-08-10 百时美施贵宝公司 用于生物制品的18f-放射性标记的方法和组合物
BR112018073642A2 (pt) 2016-05-19 2019-02-26 Bristol-Myers Squibb Company imunomoduladores para imagiologia tep
US10994033B2 (en) 2016-06-01 2021-05-04 Bristol-Myers Squibb Company Imaging methods using 18F-radiolabeled biologics

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725295A (en) * 1971-07-20 1973-04-03 Atomic Energy Commission Technetium labeling
US4057617A (en) * 1975-05-15 1977-11-08 Abramovici J Method of labeling proteins with technetium
US4323546A (en) * 1978-05-22 1982-04-06 Nuc Med Inc. Method and composition for cancer detection in humans
US4293537A (en) * 1978-09-05 1981-10-06 Wong Dennis W Novel chemical method of labeling proteins with 99m Tc-Technetium at physiological condition
US4472371A (en) * 1979-10-29 1984-09-18 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
USRE32417E (en) * 1979-10-29 1987-05-12 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
US4401647A (en) * 1980-03-03 1983-08-30 The Regents Of The University Of Ca Radiolabeled neoglycopeptides
US4500507A (en) * 1981-10-30 1985-02-19 Wong Dennis W Diagnostic composition for radiologic imaging of neoplasms in the body and method of preparation
JPS5967228A (ja) * 1982-10-07 1984-04-16 Green Cross Corp:The 寒冷不溶性グロブリンの凍結乾燥方法
JPS61501321A (ja) * 1984-01-23 1986-07-03 インスティテュト・フォ−・エネジテクニク たんぱく様物質標識用テクネチウム９９ｍ組成物およびその使用方法
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
DE3728599A1 (de) * 1986-12-10 1988-06-23 Hoechst Ag Verfahren zur herstellung einer mit technetium-99m-markierten organspezifischen substanz
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
WO1988007382A2 (en) * 1987-04-02 1988-10-06 Centocor Cardiovascular Imaging Partners, L.P. Method for labelling antibodies with a metal ion
US5061641A (en) * 1988-04-01 1991-10-29 Immunomedics, Inc. Method for radiolabeling proteins
FR2650672A1 (fr) * 1989-08-02 1991-02-08 Medgenix Group Sa Procede de marquage de proteines ou polypeptides au technetium-99m, conjugue obtenu, utilisation a titre d'agent d'imagerie, kit de reconstitution desdits conjugues
US5078985A (en) * 1989-08-09 1992-01-07 Rhomed, Incorporated Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction

Also Published As

Publication number Publication date
EP0403225A2 (de) 1990-12-19
AU647028B2 (en) 1994-03-17
ATE149515T1 (de) 1997-03-15
CA1335268C (en) 1995-04-18
JPH05500800A (ja) 1993-02-18
US5128119A (en) 1992-07-07
KR920700689A (ko) 1992-08-10
IL94690A (en) 1995-06-29
AU5924990A (en) 1991-01-08
DE69030025T2 (de) 1997-06-19
EP0403225A3 (de) 1992-08-12
DE69030025D1 (de) 1997-04-10
KR0178961B1 (ko) 1999-03-20
IL94690A0 (en) 1991-04-15
ES2098250T3 (es) 1997-05-01
WO1990015626A1 (en) 1990-12-27
EP0403225B1 (de) 1997-03-05
JP2769244B2 (ja) 1998-06-25

Similar Documents

Publication Publication Date Title
FI915832A0 (fi) Foerfarande foer maerkning av proteiner med teknetium eller rhenium.
FI873175A0 (fi) Anordning foer anslutning av ett litet roer till en apparat avsedd foer inpassning av en injektionsspruta till en laekemedelsflaska.
BR8401735A (pt) Processo para a geracao de uma especie de peroxiacido,composicao e processo de lavagem
DE3684085D1 (de) Reinigungsmittelzusammensetzung und verfahren zu deren herstellung.
FI824281A0 (fi) Arrangemang foer en vals som anvaends vid pappersframstaellning, i synnerhet foer upphettning av en kalandervals samt en i samband med arrangemanget anvaend vals och dess anvaendning
DE3585551D1 (de) Logikanalysator.
EP0078642A3 (en) Radiopharmaceutical composition based on technetium-99m and reagent for making it
DE3587621D1 (de) Logikanalysator.
FI833034A0 (fi) Azetidinonderivater, ett foerfarande foer deras framstaellning samt deras anvaendning som intermedii framstaellning av karbapenem-antibioter
DE3587625D1 (de) Logikanalysator.
ZA815325B (en) Method and kit for labeling red blood cells with technetium-99m
DE3587620D1 (de) Logikanalysator.
DE3577113D1 (de) Verfahren zum auswechsein von brueckenlagern.
IT8121531A0 (it) Riscaldatore solare in due parti emetodo per la sua fabbricazione.
NO861197L (no) N-hoeyere-alk(en)yl-neoalkanoamider samt antistatisk virksomme vaskemiddelblandinger som inneholder disse.
IT1149096B (it) Procedimento per l'arricchimento di solfuri metallici e composizione di raccolta impiegata
IT8421876A1 (it) Composizione e metodo per la captazione di zolfo
DK166153C (da) Trialkyltrithiophosphonater, insekticidt eller nematocidt praeparat indeholdende disse, fremgangsmaade til bekaempelse af insekter eller rodknoldsnematoder under anvendelse af naevnte forbindelser eller praeparat samt fremgangsmaade til fremstilling af en type af de naevnte forbindelser
IT8123812A0 (it) Processo per la separazione di isotopi con il metodo della distribuzione regolata utilizzando in particolare l'effetto di concentrazione isotopica.
PT82424B (pt) Processo para a preparacao de trans-(-)-1 beta-etil-1alfa-hidroximetil 1,2,3,4,6,7,12b alfa-octahidro-indolo {2.3-a}quinolizina e de composicoes farmaceuticas que as contem
DK368686A (da) Forbedret spindeltaetning i smurte koniske kegleventiler
AT379393B (de) Verfahren zur herstellung neuer 6-hydrazono-pyrido(2,1-b)chinazolin-11-on-deriv te, von deren salzen sowie von deren stereomeren
DK51785A (da) 1,4-aminoalkylamino-9h-thioxanthen-9-oner, laegemidler indeholdende disse samt fremgangsmaade til fremstilling deraf
BR8107202A (pt) Processo para remocao de sulfeto de hidrogenio e de amonia
ATA284384A (de) Verfahren zur herstellung neuer 6-hydrazono-pyrido(2,1-b)chinazolin-11-on-deriv te, von deren salzen sowie von deren stereomeren